November 30, 2016
SVIN Announces Worldwide Effort to Increase Use of Mechanical Thrombectomy for Stroke
November 30, 2016—The Society of Vascular and Interventional Neurology (SVIN) recently announced the launch of Mission Thrombectomy 2020, an initiative to enhance global efforts to improve stroke care worldwide by increasing the rate of mechanical thrombectomy for eligible patients from the current rate of < 100,000 procedures to 202,000 annually by 2020 and thereby reducing global stroke disability.
The initiative was unveiled at the SVIN 9th Annual Meeting and 4th Annual Stroke Center Workshop, which took place from November 16–19 in New York City. SVIN noted that mechanical thrombectomy is the new standard of care to effectively reverse paralysis from stroke in more than 60% of patients if performed within 6 hours of stroke symptom onset.
Mission Thrombectomy 2020 is led by Dileep Yavagal, MD, who is Past President of SVIN. In the announcement, Dr. Yavagal commented, "In 2015, mechanical thrombectomy was definitively proven to be enormously beneficial in reversing stroke disability and became standard of care for stroke patients with blockage of one of the main brain arteries. This has revolutionized the treatment for such patients." He continued, "SVIN has set an ambitious worldwide goal to treat every eligible stroke patients emergently with mechanical thrombectomy, but this can only be achieved if we maximize access to hospitals with mechanical thrombectomy capability of severe stroke with within 6 hours of their symptoms."
SVIN President Raul Nogueira, MD, added, "Mission Thrombectomy 2020 advances the overall mission of SVIN of innovation to improve outcomes of the largest number of stroke patients all over the world. This campaign will consolidate various efforts from multiple stakeholders with a clear patient metric to be achieved in 3 years."
According to the society, to maximize access to thrombectomy for the potential 1.7 million patients worldwide with stroke due to a large artery blockage, SVIN aims to partner with several nonprofit medical societies, governmental, and industry collaborators worldwide to achieve their initiative by focusing on efforts to improve public awareness for stroke symptoms, supporting legislation to encourage rapid triage of stroke patients, establishing financial initiatives to improve access to care for countries without health insurance, and encouraging the development of new technologies to improve stroke assessment and treatment.